Skip to content

Faculty profile

Karl Bélanger

Back to faculty
ProfessorDepartment of MedicineUniversité de Montréal

Research

Read how they describe their research on their Université de Montréal profile.

Latest papers

  • Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial.

    Journal for immunotherapy of cancer · 2025

  • Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.

    Nature medicine · 2023

  • Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors.

    Oncoimmunology · 2019

All 3 publications

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction